Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077

被引:37
|
作者
Landovitz, Raphael J. [1 ,2 ]
Zangeneh, Sahar Z. [3 ]
Chau, Gordon [3 ]
Grinsztejn, Beatriz [4 ]
Eron, Joseph J. [5 ]
Dawood, Halima [6 ]
Magnus, Manya [7 ]
Liu, Albert Y. [8 ]
Panchia, Ravindre [9 ]
Hosseinipour, Mina C. [10 ]
Kofron, Ryan [1 ,2 ]
Margolis, David A. [11 ]
Rinehart, Alex [11 ]
Adeyeye, Adeola [12 ]
Burns, David [12 ]
McCauley, Marybeth [13 ]
Cohen, Myron S. [5 ]
Currier, Judith S. [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Ctr AIDS Res & Educ, Dept Med,Div Infect Dis, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Ctr HIV Prevent, Los Angeles, CA 90095 USA
[3] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA
[4] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas INI, Lab HIV, Rio De Janeiro, Brazil
[5] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USA
[6] Univ KwaZulu Natal, Dept Med, Durban, South Africa
[7] George Washington Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Milken Inst, Washington, DC USA
[8] San Francisco Dept Publ Hlth, Populat Hlth Div, Bridge HIV, San Francisco, CA USA
[9] Univ Witwatersrand, Perinatal HIV Res Unit, Chris Hani Baragwanath Acad Hosp, Soweto, South Africa
[10] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27515 USA
[11] ViiV Healthcare, Res Triangle Pk, Durham, NC USA
[12] NIAID, Div AIDS, NIH, Rockville, MD USA
[13] FHI 360, Sci Facilitat Dept, FHI 360, Washington, DC USA
基金
美国国家卫生研究院;
关键词
cabotegravir; CAB; weight gain; HIV uninfected; DOLUTEGRAVIR; THERAPY; ADULTS;
D O I
10.1093/cid/ciz439
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Studies in human immunodeficiency virus (HIV)-infected individuals suggest excess weight gain with integrase inhibitor-based antiretroviral therapy. The HIV Prevention Trials Network Study 077 evaluated changes in weight and fasting metabolic parameters in HIV-uninfected individuals randomized to cabotegravir or a placebo. No differences between arms were found for change in weight or fasting metabolic parameters overall or for subgroups.
引用
收藏
页码:319 / 322
页数:4
相关论文
共 50 条
  • [1] Brief Report: Hormonal Contraception Use and Cabotegravir Pharmacokinetics in HIV-Uninfected Women Enrolled in HPTN 077
    Blair, Cherie S.
    Li, Sue
    Chau, Gordon
    Cottle, Leslie
    Richardson, Paul
    Marzinke, Mark A.
    Eshleman, Susan H.
    Adeyeye, Adeola
    Rinehart, Alex R.
    Margolis, David
    McCauley, Marybeth
    Hendrix, Craig W.
    Landovitz, Raphael J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 85 (01) : 93 - 97
  • [2] Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1
    McPherson, Tristan D.
    Sobieszczyk, Magdalena E.
    Markowitz, Martin
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 413 - 420
  • [3] Point-of-care Capillary Blood Lactate Measurements in Human Immunodeficiency Virus-uninfected Children With In Utero Exposure to Human Immunodeficiency Virus and Antiretroviral Medications
    Crain, Marilyn J.
    Williams, Paige L.
    Griner, Ray
    Tassiopoulos, Katherine
    Read, Jennifer S.
    Mofenson, Lynne M.
    Rich, Kenneth C.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (12) : 1069 - 1074
  • [4] Medical ICU Admission Diagnoses and Outcomes in Human Immunodeficiency Virus-Infected and Virus-Uninfected Veterans in the Combination Antiretroviral Era
    Akguen, Kathleen M.
    Tate, Janet P.
    Pisani, Margaret
    Fried, Terri
    Butt, Adeel A.
    Gibert, Cynthia L.
    Huang, Laurence
    Rodriguez-Barradas, Maria C.
    Rimland, David
    Justice, Amy C.
    Crothers, Kristina
    CRITICAL CARE MEDICINE, 2013, 41 (06) : 1458 - 1467
  • [5] Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
    Landovitz, Raphael J.
    Li, Sue
    Grinsztejn, Beatriz
    Dawood, Halima
    Liu, Albert Y.
    Magnus, Manya
    Hosseinipour, Mina C.
    Panchia, Ravindre
    Cottle, Leslie
    Chau, Gordon
    Richardson, Paul
    Marzinke, Mark A.
    Hendrix, Craig W.
    Eshleman, Susan H.
    Zhang, Yinfeng
    Tolley, Elizabeth
    Sugarman, Jeremy
    Kofron, Ryan
    Adeyeye, Adeola
    Burns, David
    Rinehart, Alex R.
    Margolis, David
    Spreen, William R.
    Cohen, Myron S.
    McCauley, Marybeth
    Eron, Joseph J.
    PLOS MEDICINE, 2018, 15 (11):
  • [7] Induction therapy with high-dose fluconazole plus flucytosine for human immunodeficiency virus-uninfected cryptococcal meningitis patients: Feasible or not?
    Zhao, Hua-Zhen
    Cheng, Jia-Hui
    Zhou, Ling-Hong
    Luo, Yu
    Zhu, Rong-Sheng
    Jiang, Ying-Kui
    Wang, Xuan
    Zhu, Li-Ping
    MYCOSES, 2023, 66 (01) : 59 - 68
  • [8] Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
    Marzinke, Mark A.
    Grinsztejn, Beatriz
    Fogel, Jessica M.
    Piwowar-Manning, Estelle
    Li, Maoji
    Weng, Lei
    McCauley, Marybeth
    Cummings, Vanessa
    Ahmed, Shahnaz
    Haines, Casey D.
    Bushman, Lane R.
    Petropoulos, Christos
    Persaud, Deborah
    Adeyeye, Adeola
    Kofron, Ryan
    Rinehart, Alex
    St Clair, Marty
    Rooney, James F.
    Pryluka, Daniel
    Coelho, Lara
    Gaur, Aditya
    Middelkoop, Keren
    Phanuphak, Nittaya
    Cohen, Myron S.
    Hendrix, Craig W.
    Anderson, Peter
    Hanscom, Brett
    Donnell, Deborah
    Landovitz, Raphael J.
    Eshleman, Susan H.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (09) : 1581 - 1592
  • [9] Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084
    Eshleman, Susan H.
    Fogel, Jessica M.
    Piwowar-Manning, Estelle
    Chau, Gordon
    Cummings, Vanessa
    Agyei, Yaw
    Richardson, Paul
    Sullivan, Philip
    Haines, Casey D.
    Bushman, Lane R.
    Petropoulos, Christos
    Persaud, Deborah
    Kofron, Ryan
    Hendrix, Craig W.
    Anderson, Peter L.
    Farrior, Jennifer
    Mellors, John
    Adeyeye, Adeola
    Rinehart, Alex
    St Clair, Marty
    Ford, Susan
    Rooney, James F.
    Mathew, Carrie-Anne
    Hunidzarira, Portia
    Spooner, Elizabeth
    Mpendo, Juliet
    Nair, Gonasagrie
    Cohen, Myron S.
    Hughes, James P.
    Hosseinipour, Mina
    Hanscom, Brett
    Delany-Moretlwe, Sinead
    Marzinke, Mark A.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (10) : 1741 - 1749
  • [10] Contemporary Treatment Approaches for Human Immunodeficiency Virus Infection: Association of Antiretrovirals with Weight Gain and Potential Solutions
    Shroba, Jenny
    Januszka, Jenna
    NURSING CLINICS OF NORTH AMERICA, 2024, 59 (02) : 189 - 200